| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
206 |
| issn |
0012-6667
1179-1950 |
| issueIdentifier |
2 |
| pageRange |
201-206 |
| publicationName |
Drugs |
| startingPage |
201 |
| bibliographicCitation |
Scott LJ. Larotrectinib: First Global Approval. Drugs. 2019 Feb;79(2):201–6. doi: 10.1007/s40265-018-1044-x. PMID: 30635837. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_681f844994de1140c27274a8d28e35bf |
| date |
2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/30635837
https://doi.org/10.1007/s40265-018-1044-x |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/1179-1950
https://portal.issn.org/resource/ISSN/0012-6667 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Larotrectinib: First Global Approval |
| discusses |
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M000641197
http://id.nlm.nih.gov/mesh/M0023875
http://id.nlm.nih.gov/mesh/M0328256
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018226 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46188928
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 |